Purus Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Purus Wealth Management's PFE Position: Q2 2026 in Review
Purus Wealth Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,192 shares — an estimated $202K sold.
Purus Wealth Management first reported a position in PFE in Q2 2022 and held it in 4 quarters. The position peaked at $226K in Q2 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Purus Wealth Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Purus Wealth Management sold 7,192 Pfizer shares in Q2 2026, an estimated $202K.
- Purus Wealth Management first reported a position in Pfizer in Q2 2022 and held it in 4 quarters.
- Purus Wealth Management's Pfizer position peaked at $226K in Q2 2022.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Purus Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.